DOES DONOR SPECIFIC ANTIBODY HLA CLASS MATTER IN PEDIATRIC HEART TRANSPLANTATION?

被引：0
|
作者：
Gambetta, Katheryn [1 ]
Tambur, Anat [1 ]
Pahl, Elfriede [1 ]
机构：
[1] Childrens Mem Hosp, Chicago, IL 60614 USA
来源：
PEDIATRIC TRANSPLANTATION | 2011年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
55
引用
收藏
页码：55 / 55
页数：1
相关论文
共 50 条
  • [21] Mycophenolate mofetil (MMF) effect on anti-HLA donor-specific antibody (DSA) after pediatric living donor transplantation.
    Ueno, Takehisa
    Takase, Koki
    Uga, Naoko
    Deguchi, Koichi
    Nomura, Motonari
    Watanabe, Miho
    Kamiyama, Masafumi
    Kimura, Takeshi
    Okuyama, Hiroomi
    TRANSPLANTATION, 2024, 108 (9S)
  • [22] Incidence and Importance of Donor-Specific HLA Antibody in Heart Transplant Recipients
    Zhang, Q.
    McNamara, J.
    Cadeiras, M.
    Khuu, T.
    Baas, A.
    Depasquale, E. C.
    Halnon, N.
    Perens, G.
    Carlos, J. A.
    Nsair, A.
    Shemin, R.
    Murray, K.
    Ardehali, A.
    Deng, M.
    Reed, E. F.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (04): : S24 - S25
  • [23] Successful primary deceased donor transplantation in the presence of donor-specific HLA class I antibody without IVIg or plasmapheresis therapy.
    Bryan, CF
    McDonald, SB
    Luger, AM
    Winklhofer, FT
    Borkon, AM
    Shield, CF
    Warady, BA
    Aeder, MI
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 403 - 403
  • [24] When to intervene for donor-specific antibody after heart transplantation
    Njue, Faith
    Chih, Sharon
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2019, 24 (03) : 271 - 278
  • [25] TREATMENT OF ASYMPTOMATIC DONOR SPECIFIC ANTIBODY AFTER HEART TRANSPLANTATION: IS IT BENEFICIAL?
    Rushworth, Parker
    Singer-Englar, Tahli
    Patel, Nikhil
    Patel, Jignesh
    Kittleson, Michelle
    Chang, David
    Kransdorf, Evan
    Kobashigawa, Jon
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 571 - 571
  • [26] Does the Development of Donor Specific Antibody after Heart Transplantation Depend on the Presence or Absence of Corticosteroids as Maintenance Therapy?
    Patel, J.
    Kittleson, M.
    Kransdorf, E.
    Shen, A.
    Nishihara, K.
    Jamero, G.
    Azarbal, B.
    Hage, A.
    Czer, L.
    Megna, D.
    Kobashigawa, J. A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S273 - S273
  • [27] Reduced HLA Class II antibody response to proteasome inhibition in heart transplantation
    Khuu, Tam
    Cadeiras, Martin
    Wisniewski, Nicholas
    Reed, Elaine F.
    Deng, Mario C.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (06): : 863 - 865
  • [28] Donor-specific HLA alloantibodies: Impact on cardiac allograft vasculopathy, rejection, and survival after pediatric heart transplantation
    Tran, Andrew
    Fixler, David
    Huang, Rong
    Meza, Tiffany
    Lacelle, Chantale
    Das, Bibhuti B.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (01): : 87 - 91
  • [29] IDENTIFICATION OF IMMUNOGENIC RECIPIENT HLA CLASS II AND DONOR-HLA-DERIVED PEPTIDE COMPLEXES: CLINICAL RELEVANCE TO DE NOVO DONOR-SPECIFIC HLA ANTIBODY FORMATION IN KIDNEY TRANSPLANTATION
    Tomosugi, Toshihide
    Iwasaki, Kenta
    Futamura, Kenta
    Okada, Manabu
    Hiramitsu, Takahisa
    Tsujita, Makoto
    Goto, Norihiko
    Narumi, Shunji
    Watarai, Yoshihiko
    Kobayashi, Takaaki
    Niemann, Matthias
    Spierings, Eric
    TRANSPLANT INTERNATIONAL, 2019, 32 : 88 - 88
  • [30] HLA antibodies in pediatric heart transplantation
    Ho, Eric K.
    Vasilescu, Elena R.
    Vlad, George
    Marboe, Charles C.
    Addonizio, Linda J.
    Suciu-Foca, Nicole
    PEDIATRIC TRANSPLANTATION, 2011, 15 (05) : 458 - 464
12345